Detalhe da pesquisa
1.
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.
J Intern Med
; 291(5): 676-693, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233860
2.
Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets.
Front Immunol
; 14: 1133435, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033920
3.
Differences between early vs. late-onset of psoriatic arthritis: Data from the RESPONDIA and REGISPONSER registries.
Joint Bone Spine
; 90(4): 105563, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934781
4.
Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Ther Adv Chronic Dis
; 11: 2040622320965067, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796240
5.
Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
Ther Adv Musculoskelet Dis
; 11: 1759720X19880742, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662800